Some authors have demonstrated lower IFN-γ levels and decreased T-cell infiltration in EGFR-mutated NSCLC [69], which suggests decreased immunogenicity or suppression of the immune response in the TME. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.